Medicine / D-0821-2026
U.S. Food and Drug AdministrationD-0821-2026
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile…
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
Recalling firm
Baxter Healthcare Corporation
Reason for recall
CGMP Deviations
Where it went
US Nationwide; Puerto Rico; and Chile.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.